Abstract
The article reviews current doctrines for holding manufacturers of pharmaceuticals liable for failing to adequately warn of potential adverse effects. The article explains basic concepts of product liability and reviews current cases that address which ad verse effects require warnings and to whom the warnings must be given. The article also examines the interactions between compliance with Food and Drug Administra tion (FDA) regulations and potential civil liability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.